SNDX Syndax Pharmaceuticals, Inc.
Price Chart
Executive Summary
Syndax Pharmaceuticals granted inducement awards for 66,700 shares to four new employees under the 2023 Inducement Plan. The stock options vest over four years with a one-year cliff. This is a routine compensation event with no material impact on the company's financials or operations.
Actionable Insight
Routine inducement grants have no near-term trading implications. Monitor for any future updates on employee retention or material changes in insider ownership.
Key Facts
- Inducement awards granted on June 1, 2026
- 66,700 shares of common stock awarded to four new employees
- Options vest over four years with 25% after one year and monthly thereafter
Financial Impact
Minimal; 66,700 shares represent less than 0.1% of outstanding shares based on market cap of $1.6B
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3307077 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
2d ago
|
Press Release
| $18.02 awaiting T+1 | awaiting T+1 | — | $17.34 (−3.77%) |
|
Jun 4, 2026
2d ago
|
DEFA14A
| $18.02 $17.34 | ▼ −3.77% | ▼ −1.18% | $17.34 (−3.77%) |
|
Jun 4, 2026
2d ago
|
8-K
| — | awaiting T+1 | — | — |
|
Apr 30, 2026
5w ago
|
DEFA14A
| $19.11 $19.96 | ▲ +4.45% | ▲ +4.79% | $17.34 (−9.26%) |
|
Apr 24, 2026
6w ago
|
Press Release
| $21.39 $21.00 | ▼ −1.82% | ▼ −1.99% | $17.34 (−18.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access